Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies Tomasz Sacha; Katarzyna Krawczyk;

Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic Fabio Pires de Souza Santos; Renato Sampaio Tavares; Katia Borgia Barbosa Pagnano;

Quantitative detection of T315I mutations of BCR::ABL1 using digital droplet polymerase chain reaction Huijun Mu; Jian Zou; Haiping Zhang;